Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$7.0 - $14.77 $1.47 Million - $3.1 Million
209,917 New
209,917 $3.06 Million
Q3 2021

Nov 12, 2021

SELL
$9.63 - $12.47 $334,103 - $432,634
-34,694 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$10.9 - $14.29 $378,164 - $495,777
34,694 New
34,694 $421,000

Others Institutions Holding AMYT

About Amryt Pharma plc


  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Yakira Capital Management, Inc. Portfolio

Follow Yakira Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yakira Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Yakira Capital Management, Inc. with notifications on news.